Eye implant showdown: which tiny drain works best for glaucoma?

NCT ID NCT07623434

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compared two small eye implants, Hydrus and iStent, placed during cataract surgery to help lower eye pressure in people with open-angle glaucoma. 65 patients were followed long-term to see which device worked better and was safer. The goal was to reduce the need for glaucoma medications and protect vision.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Hydrus microimplant or iStent microimplant (both are tiny devices placed in the eye during cataract surgery to help drain fluid and lower eye pressure)
What this could lead to
If one device proves better, it could become the preferred option for managing glaucoma during cataract surgery, helping patients maintain vision with fewer eye drops.
What could go wrong
This is a small, completed study (65 people) comparing two existing devices, so it won't lead to a new treatment. Results may not apply to all glaucoma patients, and both devices carry surgical risks like infection or implant misplacement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Military Institute of Medicine - National Research Institute

    Warsaw, Mazovian, 04-141, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.